Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

Conditions:   Metastatic Malignant Neoplasm in the Brain;   Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8;   St age IV Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8 Interventions:   Drug: Duvelisib;   Biological: Nivolumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials